Q1 EPS Estimate for Aligos Therapeutics Reduced by Analyst
Aligos Therapeutics, Inc. (NASDAQ:ALGS – Free Report) – Research analysts at HC Wainwright lowered their Q1 2026 earnings per share estimates for Aligos Therapeutics in a research note issued to investors on Wednesday, March 11th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of ($2.53) for the quarter, […]
17 Mar 05:12 · The Markets Daily